Financials data is unavailable for this security.
View more
Year on year LifeStance Health Group Inc grew revenues 18.50% from 1.06bn to 1.25bn while net income improved from a loss of 186.26m to a smaller loss of 57.44m.
| Gross margin | -- |
|---|---|
| Net profit margin | -0.67% |
| Operating margin | 0.52% |
| Return on assets | -0.43% |
|---|---|
| Return on equity | -0.62% |
| Return on investment | -0.48% |
More ▼
Cash flow in USDView more
In 2024, LifeStance Health Group Inc increased its cash reserves by 96.10%, or 75.75m. The company earned 107.26m from its operations for a Cash Flow Margin of 8.57%. In addition the company used 21.57m on investing activities and also paid 9.95m in financing cash flows.
| Cash flow per share | 0.1212 |
|---|---|
| Price/Cash flow per share | 58.34 |
| Book value per share | 3.84 |
|---|---|
| Tangible book value per share | 0.0479 |
More ▼
Balance sheet in USDView more
| Current ratio | 1.58 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.189 |
|---|---|
| Total debt/total capital | 0.1589 |
More ▼
